✦ LIBER ✦

Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study

✍ Scribed by Grottoli, S.; Celleno, R.; Gasco, V.; Pivonello, R.; Caramella, D.; Barreca, A.; Ragazzoni, F.; Pigliaru, F.; Alberti, D.; Ferrara, R.; Angeletti, G.

Book ID: 125335904
Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 102 KB
Volume: 28
Category: Article
ISSN: 0391-4097
DOI: 10.1007/BF03345335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Efficacy and Safety of Switching to

The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study

✍ Lee, Hwang-Bin; Yoon, Bo-Hyun; Kwon, Young-Joon; Woo, Young Sup; Lee, Jung-Goo; 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 381 KB

Open label non comparative study of the

Open label non comparative study of the efficacy tolerability and safety with fluvastatin (LESCOL®) 40 MG once daily during 12 weeks in 79 Ecuadorian dyslipidemic patients with coronary heart disease

✍ J. Páez; L. Alvarado; D. Toral; B. Delgado 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Efficacy and Safety Profile of Exenatide

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

✍ Inagaki, Nobuya; Atsumi, Yoshihito; Oura, Tomonori; Saito, Hitoshi; Imaoka, Take 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 962 KB